From Dossier to Dispatch: Indian Generic Drug Documentation for Export

Exporting pharmaceutical products from India involves a multi-layered documentation process that spans regulatory compliance, product quality, and customs/trade logistics. For international buyers, understanding which documents exist — and what each one tells you — helps you manage your import process more efficiently and ask better questions of your supplier.

---

Regulatory Export Framework: The Basics

Pharmaceutical exports from India are governed primarily by: - Drugs & Cosmetics Act, 1940 and Drugs Rules, 1945 — the core pharma regulatory framework - DGFT (Directorate General of Foreign Trade) — export licensing and foreign trade policy - CDSCO (Central Drugs Standard Control Organisation) — central drug regulator, issues export-related certificates

---

Key Document 1: Certificate of Analysis (CoA)

The CoA is perhaps the most important batch-level quality document. Issued by the manufacturer's quality control lab, it states: - Product name, strength, and form - Batch number and batch size - Manufacturing and expiry dates - Tests performed, specifications, and actual results - Reference to the applicable pharmacopoeia (Indian Pharmacopoeia/IP, British Pharmacopoeia/BP, USP, or in-house) - QC analyst and authorised signatory

Every shipment should be accompanied by a CoA matching the batch number of the goods dispatched. Verify that the CoA is on the manufacturer's letterhead (not a trader's re-issued document) and that test results fall within specification.

---

Key Document 2: Form 40 / Form 41 — Export NOC

Under the Drugs Rules, an exporter seeking to export certain drugs requires a No Objection Certificate (NOC) from CDSCO: - Form 40: Application for permission to export drugs - Form 41: The export NOC issued by CDSCO

Not all products require a Form 41 — the requirement depends on product type and destination. Your supplier or a regulatory consultant can advise whether the specific product you are procuring requires a Form 41 and what the lead time for obtaining one is. This is worth confirming early, as delays in obtaining the NOC can affect shipment timelines.

---

Key Document 3: Free Sale Certificate (FSC)

A Free Sale Certificate (also called a Certificate of Free Sale or Certificate of Pharmaceutical Product/CPP) attests that the product is freely marketed and sold in India and that the manufacturer holds a valid manufacturing licence. It is issued by CDSCO or State FDAs.

Many regulatory authorities in Africa, Southeast Asia, and the Middle East require an FSC as part of product import registration. Confirm whether your importing country requires an FSC and whether it needs to be apostilled or legalised.

---

Key Document 4: WHO CPP (Certificate of Pharmaceutical Product)

The WHO CPP format (from WHO Technical Report Series) is a specific version of the free sale certificate that follows a WHO-defined format. Some countries specifically require the CPP format rather than a generic FSC. Your supplier should be able to obtain this from CDSCO.

---

Key Document 5: GMP Certificate

As discussed in detail in our WHO-GMP post, the manufacturer's GMP certificate is a regulatory quality credential. For import registration in most markets, you will need to submit the manufacturer's current GMP certificate alongside product documentation.

---

Key Document 6: CTD Dossier (for Product Registration)

If you are registering an Indian generic medicine in your country's regulatory system for the first time, you will need a Common Technical Document (CTD) dossier — the standard international format for product registration submissions.

The CTD covers: - Module 1: Administrative and regional information (country-specific) - Module 2: Summaries and overviews - Module 3: Quality (pharmaceutical development, manufacture, specifications, stability) - Module 4: Non-clinical study reports (may rely on reference product data for generics) - Module 5: Clinical study reports (for generics, this typically involves a bioequivalence study)

Not every importer needs a full CTD — for some countries and product categories, a simplified dossier or reference to a WHO Prequalified product is sufficient. A local regulatory consultant is essential for navigating your country's specific requirements.

---

Shipment-Level Trade Documents

For each export consignment, standard trade documents include:

| Document | Purpose | |---------|---------| | Commercial Invoice | States goods description, quantity, price, Incoterm, seller/buyer details | | Packing List | Itemises contents by carton (product, batch, qty, weight) | | Bill of Lading / Airway Bill | Transport document — proof of shipment | | Certificate of Origin | Certifies Indian origin for customs/preferential duty purposes | | Shipping Bill | Indian customs export declaration | | Insurance Certificate | Proof of cargo insurance (where CIF or CIP Incoterm applies) |

---

Bharat Medex's Documentation Process

We coordinate the full export documentation package for each shipment — CoA from manufacturer, trade documents from our end, and facilitation of FSC/CPP/Form 40-41 where required. We brief buyers on lead times for regulatory documents so there are no surprise delays.